CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Eli Lilly and Company Company Snapshot
Eli Lilly and Company operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Eli Lilly and Company with three other companies in this sector in the United States: Abbott Laboratories (2015 sales of $20.41 billion of which 34% was Nutritionals), Abbvie Inc ($22.86 billion of which 100% was Pharmaceutical Products), and Teva Pharmaceutical Industries Limited ($19.65 billion of which 49% was Generic Madicines).

Sales Analysis. Eli Lilly and Company reported sales of $19.96 billion for the year ending December of 2015. This represents a very small increase of 1.7% versus 2014, when the company's sales were $19.62 billion. Despite this increase, sales are still well below the level achieved in 2013, when Eli Lilly and Company reported sales of $23.11 billion. Sales of Animal Health saw an increase that was more than double the company's growth rate: sales were up 35.6% in 2015, from $2.35 billion to $3.18 billion. Eli Lilly and Company also saw significant increases in sales in Oncology (up 3.4% to $3.51 billion) . Not all segments of Eli Lilly and Company experienced an increase in sales in 2015: sales of Other Pharmaceutical fell 20.7% to $227.70 million. (However, this segment's sales were only a very small portion of the company's overall sales). Eli Lilly and Company also experienced decreases in sales in Neurosciences (down 18.4% to $2.94 billion) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Eli Lilly and Company
  Stock Performance Chart for Eli Lilly and Company
 
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 67.71
(Figures in U.S. Dollars)
1 Week -2.0%   13 Weeks -6.6%  
4 Weeks -11.9%   52 Weeks -21.8%  
 
Eli Lilly and Company Key Data:
  Ticker: LLY Country: United States
  Exchanges: NYSE FRA LON MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 19,958,700,000
(Year Ending Jan 2016).
Employees: 41,275
  Currency: U.S. Dollars Market Cap: 74,836,680,630
  Fiscal Yr Ends: December Shares Outstanding: 1,105,253,000
  Share Type: Common Closely Held Shares: 3,919,903
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.